T1	NP 0 4	Niña
#1	Norm T1	niña NP00000
T2	SP 5 7	de
#2	Norm T2	de SPS00
T3	Z 8 10	20
#3	Norm T3	20 Z
T4	NC 11 16	meses
#4	Norm T4	mes NCMP000
T5	PR 17 20	que
#5	Norm T5	que PR0CN000
T6	VM 21 28	ingresa
#6	Norm T6	ingresar VMIP3S0
T7	SP 29 32	por
#7	Norm T7	por SPS00
T8	NC 33 41	síndrome
#8	Norm T8	síndrome NCMS000
T9	AQ 42 48	febril
#9	Norm T9	febril AQ0CS0
T10	VM 49 59	prolongado
#10	Norm T10	prolongar VMP00SM
T11	SP 60 62	de
#11	Norm T11	de SPS00
T12	Z 63 64	5
#12	Norm T12	5 Z
T13	NC 65 70	meses
#13	Norm T13	mes NCMP000
T14	SP 71 73	de
#14	Norm T14	de SPS00
T15	NC 74 83	evolución
#15	Norm T15	evolución NCFS000
T16	Fc 83 84	,
#16	Norm T16	, Fc
T17	AQ 85 97	intermitente
#17	Norm T17	intermitente AQ0CS0
T18	SP 98 100	en
#18	Norm T18	en SPS00
T19	DA 101 104	los
#19	Norm T19	el DA0MP0
T20	AO 105 113	primeros
#20	Norm T20	1 AO0MP0
T21	NC 114 119	meses
#21	Norm T21	mes NCMP000
T22	CC 120 121	y
#22	Norm T22	y CC
T23	AQ 122 131	constante
#23	Norm T23	constante AQ0CS0
T24	SP 132 134	en
#24	Norm T24	en SPS00
T25	DA 135 138	los
#25	Norm T25	el DA0MP0
T26	Z 139 140	2
#26	Norm T26	2 Z
T27	AQ 141 151	siguientes
#27	Norm T27	siguiente AQ0CP0
T28	Fc 151 152	,
#28	Norm T28	, Fc
T29	SP 153 156	con
#29	Norm T29	con SPS00
T30	NC 157 168	temperatura
#30	Norm T30	temperatura NCFS000
T31	AQ 169 175	máxima
#31	Norm T31	máximo AQ0FS0
T32	AQ 176 181	menor
#32	Norm T32	menor AQ0CS0
T33	SP 182 184	de
#33	Norm T33	de SPS00
T34	Z 185 187	39
#34	Norm T34	39 Z
T35	CC 187 188	o
#35	Norm T35	o CC
T36	CC 189 190	e
#36	Norm T36	y CC
T37	AQ 191 203	intermitente
#37	Norm T37	intermitente AQ0CS0
T38	SP 204 206	en
#38	Norm T38	en SPS00
T39	DA 207 210	los
#39	Norm T39	el DA0MP0
T40	Z 211 214	dos
#40	Norm T40	2 Z
T41	AO 215 222	últimos
#41	Norm T41	último AO0MP0
T42	NC 223 228	meses
#42	Norm T42	mes NCMP000
T43	Fp 228 229	.
#43	Norm T43	. Fp
T44	VM 230 238	Presenta
#44	Norm T44	presentar VMIP3S0
T45	NC 239 247	exantema
#45	Norm T45	exantema NCMS000
T46	AQ 248 271	maculopapuloeritematoso
#46	Norm T46	maculopapuloeritematoso AQ0MS0
T47	Fc 271 272	,
#47	Norm T47	, Fc
T48	AQ 273 284	evanescente
#48	Norm T48	evanescente AQ0CS0
T49	SP 285 287	en
#49	Norm T49	en SPS00
T50	NC 288 294	tronco
#50	Norm T50	tronco NCMS000
T51	CC 295 296	y
#51	Norm T51	y CC
T52	NC 297 302	parte
#52	Norm T52	parte NCFS000
T53	AQ 303 311	proximal
#53	Norm T53	proximal AQ0CS0
T54	SP 312 314	de
#54	Norm T54	de SPS00
T55	NC 315 327	extremidades
#55	Norm T55	extremidad NCFP000
T56	Fc 327 328	,
#56	Norm T56	, Fc
T57	NC 329 344	linfadenopatías
#57	Norm T57	linfadenopatía NCFP000
T58	SP 345 350	desde
#58	Norm T58	desde SPS00
T59	DA 351 354	los
#59	Norm T59	el DA0MP0
T60	Z 355 357	13
#60	Norm T60	13 Z
T61	NC 358 363	meses
#61	Norm T61	mes NCMP000
T62	SP 364 366	de
#62	Norm T62	de SPS00
T63	NC 367 371	edad
#63	Norm T63	edad NCFS000
T64	Fc 371 372	,
#64	Norm T64	, Fc
T65	VM 373 382	afectando
#65	Norm T65	afectar VMG0000
T66	SP 383 384	a
#66	Norm T66	a SPS00
T67	NC 385 393	ganglios
#67	Norm T67	ganglio NCMP000
T68	AQ 394 404	cervicales
#68	Norm T68	cervical AQ0CP0
T69	Fc 404 405	,
#69	Norm T69	, Fc
T70	AQ 406 414	axilares
#70	Norm T70	axilar AQ0CP0
T71	CC 415 416	e
#71	Norm T71	y CC
T72	AQ 417 427	inguinales
#72	Norm T72	inguinal AQ0CP0
T73	CC 428 429	y
#73	Norm T73	y CC
T74	NC 430 443	hepatomegalia
#74	Norm T74	hepatomegalia NCFS000
T75	Fp 443 444	.
#75	Norm T75	. Fp
T76	SP 445 447	En
#76	Norm T76	en SPS00
T77	DA 448 451	los
#77	Norm T77	el DA0MP0
T78	NC 452 457	datos
#78	Norm T78	dato NCMP000
T79	AQ 458 468	analíticos
#79	Norm T79	analítico AQ0MP0
T80	P0 469 471	se
#80	Norm T80	se P00CN000
T81	VM 472 479	observa
#81	Norm T81	observar VMIP3S0
T82	NC 480 486	anemia
#82	Norm T82	anemia NCFS000
T83	Fpa 487 488	(
#83	Norm T83	( Fpa
T84	Z 488 491	9,3
#84	Norm T84	9.3 Z
T85	NC 492 493	g
#85	Norm T85	g NC00000
T86	Fh 493 494	/
#86	Norm T86	/ Fh
T87	NC 494 496	dl
#87	Norm T87	dl NC00000
T88	Fpt 496 497	)
#88	Norm T88	) Fpt
T89	Fc 497 498	,
#89	Norm T89	, Fc
T90	NC 499 511	leucocitosis
#90	Norm T90	leucocitosis NCFN000
T91	Fpa 512 513	(
#91	Norm T91	( Fpa
T92	Z 513 519	27.340
#92	Norm T92	27340 Z
T93	Fh 519 520	/
#93	Norm T93	/ Fh
T94	NC 520 523	mm3
#94	Norm T94	mm3 NC00000
T95	Fpt 523 524	)
#95	Norm T95	) Fpt
T96	CC 525 526	y
#96	Norm T96	y CC
T97	NC 527 530	VSG
#97	Norm T97	VSG NC00000
T98	VM 531 540	aumentada
#98	Norm T98	aumentar VMP00SF
T99	Fp 540 541	.
#99	Norm T99	. Fp
T100	DA 542 545	Las
#100	Norm T100	el DA0FP0
T101	NC 546 561	manifestaciones
#101	Norm T101	manifestación NCFP000
T102	AQ 562 570	clínicas
#102	Norm T102	clínico AQ0FP0
T103	CC 571 572	y
#103	Norm T103	y CC
T104	AQ 573 583	analíticas
#104	Norm T104	analítico AQ0FP0
T105	VM 584 592	sugieren
#105	Norm T105	sugerir VMIP3P0
T106	NP 593 597	AlJs
#106	Norm T106	aljs NP00000
T107	Fc 597 598	,
#107	Norm T107	, Fc
T108	VM 599 610	iniciándose
#108	Norm T108	iniciar+se VMG0000+PP3CN000
T109	NC 611 622	tratamiento
#109	Norm T109	tratamiento NCMS000
T110	SP 623 626	con
#110	Norm T110	con SPS00
T111	NC 627 637	prednisona
#111	Norm T111	prednisona NCFS000
T112	AQ 638 642	oral
#112	Norm T112	oral AQ0CS0
T113	SP 643 644	a
#113	Norm T113	a SPS00
T114	Z 645 646	2
#114	Norm T114	2 Z
T115	NC 647 649	mg
#115	Norm T115	mg NC00000
T116	Fh 649 650	/
#116	Norm T116	/ Fh
T117	NC 650 652	kg
#117	Norm T117	kg NC00000
T118	Fh 652 653	/
#118	Norm T118	/ Fh
T119	NC 653 656	día
#119	Norm T119	día NCMS000
T120	Fpa 657 658	(
#120	Norm T120	( Fpa
T121	Z 658 660	10
#121	Norm T121	10 Z
T122	NC 661 663	mg
#122	Norm T122	mg NC00000
T123	DI 664 668	cada
#123	Norm T123	cada DI0CS0
T124	Z 669 671	12
#124	Norm T124	12 Z
T125	NC 672 677	horas
#125	Norm T125	hora NCFP000
T126	Fpt 677 678	)
#126	Norm T126	) Fpt
T127	Fp 678 679	.
#127	Norm T127	. Fp
T128	SP 680 682	Al
#128	Norm T128	a+el SPS00+DA0MS0
T129	NC 683 686	mes
#129	Norm T129	mes NCMS000
T130	P0 687 689	se
#130	Norm T130	se P00CN000
T131	VM 690 696	reduce
#131	Norm T131	reducir VMIP3S0
T132	DA 697 699	la
#132	Norm T132	el DA0FS0
T133	NC 700 705	dosis
#133	Norm T133	dosis NCFN000
T134	VM 706 717	añadiéndose
#134	Norm T134	añadir+se VMG0000+PP3CN000
T135	DI 718 720	un
#135	Norm T135	uno DI0MS0
T136	NC 721 732	antagonista
#136	Norm T136	antagonista NCCS000
T137	SP 733 735	de
#137	Norm T137	de SPS00
T138	NC 736 744	receptor
#138	Norm T138	receptor NCMS000
T139	SP 745 747	de
#139	Norm T139	de SPS00
T140	NC 748 760	interleucina
#140	Norm T140	interleucina NCFS000
T141	Z 761 762	1
#141	Norm T141	1 Z
T142	Fpa 763 764	(
#142	Norm T142	( Fpa
T143	NC 764 772	Anakinra
#143	Norm T143	anakinra NCMS000
T144	Fpt 772 773	)
#144	Norm T144	) Fpt
T145	SP 774 775	a
#145	Norm T145	a SPS00
T146	Z 776 777	1
#146	Norm T146	1 Z
T147	NC 778 780	mg
#147	Norm T147	mg NC00000
T148	Fh 780 781	/
#148	Norm T148	/ Fh
T149	NC 781 783	kg
#149	Norm T149	kg NC00000
T150	Fh 783 784	/
#150	Norm T150	/ Fh
T151	NC 784 787	día
#151	Norm T151	día NCMS000
T152	SP 788 791	por
#152	Norm T152	por SPS00
T153	NC 792 795	vía
#153	Norm T153	vía NCFS000
T154	AQ 796 806	subcutánea
#154	Norm T154	subcutáneo AQ0FP0
T155	Fp 806 807	.
#155	Norm T155	. Fp
T156	SP 808 812	Tras
#156	Norm T156	tras SPS00
T157	Z 813 814	2
#157	Norm T157	2 Z
T158	NC 815 822	semanas
#158	Norm T158	semana NCFP000
T159	SP 823 825	de
#159	Norm T159	de SPS00
T160	NC 826 837	tratamiento
#160	Norm T160	tratamiento NCMS000
T161	VM 838 846	presenta
#161	Norm T161	presentar VMIP3S0
T162	NC 847 865	hipertransaminemia
#162	Norm T162	hipertransaminasemia NCFS000
T163	SP 866 868	de
#163	Norm T163	de SPS00
T164	AQ 869 877	probable
#164	Norm T164	probable AQ0CS0
T165	NC 878 887	etiología
#165	Norm T165	etiología NCFS000
T166	AQ 888 893	viral
#166	Norm T166	viral AQ0CS0
T167	Fc 893 894	,
#167	Norm T167	, Fc
T168	VM 895 906	retirándose
#168	Norm T168	retirar+se VMG0000+PP3CN000
T169	DA 907 909	el
#169	Norm T169	el DA0MS0
T170	NC 910 918	anakinra
#170	Norm T170	anakinra NCMS000
T171	Fc 918 919	,
#171	Norm T171	, Fc
T172	DA 920 922	lo
#172	Norm T172	el DA0NS0
T173	PR 923 926	que
#173	Norm T173	que PR0CN000
T174	VM 927 935	ocasiona
#174	Norm T174	ocasionar VMIP3S0
T175	DI 936 938	un
#175	Norm T175	uno DI0MS0
T176	NC 939 952	empeoramiento
#176	Norm T176	empeoramiento NCMS000
T177	AQ 953 960	clínico
#177	Norm T177	clínico AQ0MS0
T178	SP 961 964	con
#178	Norm T178	con SPS00
T179	NC 965 976	reaparición
#179	Norm T179	reaparición NCFS000
T180	SP 977 979	de
#180	Norm T180	de SPS00
T181	NC 980 988	lesiones
#181	Norm T181	lesión NCFP000
T182	AQ 989 997	cutáneas
#182	Norm T182	cutáneo AQ0FP0
T183	Fc 997 998	,
#183	Norm T183	, Fc
T184	NC 999 1009	artralgias
#184	Norm T184	artralgia NCFP000
T185	CC 1010 1011	y
#185	Norm T185	y CC
T186	NC 1012 1021	febrícula
#186	Norm T186	febrícula NCFS000
T187	Fc 1021 1022	,
#187	Norm T187	, Fc
T188	VM 1023 1034	necesitando
#188	Norm T188	necesitar VMG0000
T189	AQ 1035 1040	altas
#189	Norm T189	alto AQ0FP0
T190	NC 1041 1046	dosis
#190	Norm T190	dosis NCFN000
T191	SP 1047 1049	de
#191	Norm T191	de SPS00
T192	NC 1050 1061	corticoides
#192	Norm T192	corticoide NCMP000
T193	SP 1062 1066	para
#193	Norm T193	para SPS00
T194	DA 1067 1069	el
#194	Norm T194	el DA0MS0
T195	NC 1070 1077	control
#195	Norm T195	control NCMS000
T196	SP 1078 1080	de
#196	Norm T196	de SPS00
T197	DA 1081 1083	la
#197	Norm T197	el DA0FS0
T198	NC 1084 1094	enfermedad
#198	Norm T198	enfermedad NCFS000
T199	Fc 1094 1095	,
#199	Norm T199	, Fc
T200	SP 1096 1099	por
#200	Norm T200	por SPS00
T201	DA 1100 1102	lo
#201	Norm T201	el DA0NS0
T202	PR 1103 1106	que
#202	Norm T202	que PR0CN000
T203	P0 1107 1109	se
#203	Norm T203	se P00CN000
T204	VM 1110 1118	solicita
#204	Norm T204	solicitar VMIP3S0
T205	SP 1119 1120	a
#205	Norm T205	a SPS00
T206	DA 1121 1123	la
#206	Norm T206	el DA0FS0
T207	NP 1124 1144	Comisión de Farmacia
#207	Norm T207	comisión_de_farmacia NP00000
T208	CC 1145 1146	y
#208	Norm T208	y CC
T209	NP 1147 1158	Terapéutica
#209	Norm T209	terapéutica NP00000
T210	Fpa 1159 1160	(
#210	Norm T210	( Fpa
T211	NC 1160 1163	CFT
#211	Norm T211	CFT NC00000
T212	Fpt 1163 1164	)
#212	Norm T212	) Fpt
T213	SP 1165 1168	del
#213	Norm T213	de+el SPS00+DA0MS0
T214	NP 1169 1177	Hospital
#214	Norm T214	hospital NP00000
T215	DA 1178 1180	el
#215	Norm T215	el DA0MS0
T216	NC 1181 1184	uso
#216	Norm T216	uso NCMS000
T217	VS 1185 1190	fuera
#217	Norm T217	ser VSSI1S0
T218	SP 1191 1193	de
#218	Norm T218	de SPS00
T219	NC 1194 1204	indicación
#219	Norm T219	indicación NCFS000
T220	SP 1205 1207	de
#220	Norm T220	de SPS00
T221	NC 1208 1219	canakinumab
#221	Norm T221	canakinumab NC00000
T222	Fp 1219 1220	.
#222	Norm T222	. Fp
T223	NC 1221 1232	Canakinumab
#223	Norm T223	canakinumab NC00000
T224	VS 1233 1235	es
#224	Norm T224	ser VSIP3S0
T225	DI 1236 1238	un
#225	Norm T225	uno DI0MS0
T226	NC 1239 1249	anticuerpo
#226	Norm T226	anticuerpo NCMS000
T227	AQ 1250 1260	monoclonal
#227	Norm T227	monoclonal AQ0CS0
T228	RG 1261 1274	completamente
#228	Norm T228	completamente RG
T229	AQ 1275 1281	humano
#229	Norm T229	humano AQ0MS0
T230	PR 1282 1285	que
#230	Norm T230	que PR0CN000
T231	P0 1286 1288	se
#231	Norm T231	se P00CN000
T232	VM 1289 1292	une
#232	Norm T232	unir VMIP3S0
T233	SP 1293 1296	con
#233	Norm T233	con SPS00
T234	AQ 1297 1301	alta
#234	Norm T234	alto AQ0FS0
T235	NC 1302 1310	afinidad
#235	Norm T235	afinidad NCFS000
T236	SP 1311 1312	a
#236	Norm T236	a SPS00
T237	DA 1313 1315	la
#237	Norm T237	el DA0FS0
T238	NC 1316 1328	interleucina
#238	Norm T238	interleucina NCFS000
T239	NC 1329 1337	humana-1
#239	Norm T239	humana-1 NC00000
T240	NC 1338 1342	beta
#240	Norm T240	beta NCFS000
T241	Fc 1342 1343	,
#241	Norm T241	, Fc
T242	VM 1344 1357	neutralizando
#242	Norm T242	neutralizar VMG0000
T243	RG 1358 1361	así
#243	Norm T243	así RG
T244	DP 1362 1364	su
#244	Norm T244	su DP3CS0
T245	NC 1365 1374	actividad
#245	Norm T245	actividad NCFS000
T246	NC 1375 1385	biológica4
#246	Norm T246	biológica4 NC00000
T247	Fp 1385 1386	.
#247	Norm T247	. Fp
T248	SP 1387 1389	En
#248	Norm T248	en SPS00
T249	DA 1390 1392	el
#249	Norm T249	el DA0MS0
T250	NC 1393 1400	momento
#250	Norm T250	momento NCMS000
T251	SP 1401 1403	de
#251	Norm T251	de SPS00
T252	DA 1404 1406	la
#252	Norm T252	el DA0FS0
T253	NC 1407 1416	solicitud
#253	Norm T253	solicitud NCFS000
T254	NC 1417 1428	canakinumab
#254	Norm T254	canakinumab NC00000
T255	VA 1429 1435	estaba
#255	Norm T255	estar VAII1S0
T256	VM 1436 1444	indicado
#256	Norm T256	indicar VMP00SM
T257	SP 1445 1449	para
#257	Norm T257	para SPS00
T258	DA 1450 1452	el
#258	Norm T258	el DA0MS0
T259	NC 1453 1464	tratamiento
#259	Norm T259	tratamiento NCMS000
T260	SP 1465 1467	de
#260	Norm T260	de SPS00
T261	DA 1468 1471	los
#261	Norm T261	el DA0MP0
T262	NP 1472 1502	Síndromes Periódicos Asociados
#262	Norm T262	síndromes_periódicos_asociados NP00000
T263	SP 1503 1504	a
#263	Norm T263	a SPS00
T264	DA 1505 1507	la
#264	Norm T264	el DA0FS0
T265	NP 1508 1518	Criopirina
#265	Norm T265	criopirina NP00000
T266	Fpa 1519 1520	(
#266	Norm T266	( Fpa
T267	NC 1520 1524	CAPS
#267	Norm T267	CAPS NC00000
T268	Fpt 1524 1525	)
#268	Norm T268	) Fpt
T269	SP 1526 1528	en
#269	Norm T269	en SPS00
T270	NC 1529 1536	adultos
#270	Norm T270	adulto NCMP000
T271	Fc 1536 1537	,
#271	Norm T271	, Fc
T272	NC 1538 1550	adolescentes
#272	Norm T272	adolescente NCCP000
T273	CC 1551 1552	y
#273	Norm T273	y CC
T274	NC 1553 1558	niños
#274	Norm T274	niño NCMP000
T275	SP 1559 1560	a
#275	Norm T275	a SPS00
T276	VM 1561 1567	partir
#276	Norm T276	partir VMN0000
T277	SP 1568 1570	de
#277	Norm T277	de SPS00
T278	Z 1571 1572	2
#278	Norm T278	2 Z
T279	NC 1573 1577	años
#279	Norm T279	año NCMP000
T280	Fc 1577 1578	,
#280	Norm T280	, Fc
T281	CC 1579 1583	pero
#281	Norm T281	pero CC
T282	P0 1584 1586	se
#282	Norm T282	se P00CN000
T283	VM 1587 1594	dispone
#283	Norm T283	disponer VMIP3S0
T284	SP 1595 1597	de
#284	Norm T284	de SPS00
T285	DI 1598 1600	un
#285	Norm T285	uno DI0MS0
T286	NC 1601 1609	estudio5
#286	Norm T286	estudio5 NC00000
T287	RG 1610 1616	recién
#287	Norm T287	recién RG
T288	VM 1617 1626	publicado
#288	Norm T288	publicar VMP00SM
T289	SP 1627 1630	con
#289	Norm T289	con SPS00
T290	NC 1631 1641	resultados
#290	Norm T290	resultado NCMP000
T291	SP 1642 1644	de
#291	Norm T291	de SPS00
T292	DD 1645 1649	este
#292	Norm T292	este DD0MS0
T293	NC 1650 1657	fármaco
#293	Norm T293	fármaco NCMS000
T294	SP 1658 1660	en
#294	Norm T294	en SPS00
T295	NC 1661 1664	AIJ
#295	Norm T295	AIJ NC00000
T296	SP 1665 1667	en
#296	Norm T296	en SPS00
T297	NC 1668 1673	niños
#297	Norm T297	niño NCMP000
T298	SP 1674 1676	de
#298	Norm T298	de SPS00
T299	RG 1677 1680	más
#299	Norm T299	más RG
T300	SP 1681 1683	de
#300	Norm T300	de SPS00
T301	Z 1684 1685	4
#301	Norm T301	4 Z
T302	NC 1686 1690	años
#302	Norm T302	año NCMP000
T303	VM 1691 1703	administrado
#303	Norm T303	administrar VMP00SM
T304	SP 1704 1705	a
#304	Norm T304	a SPS00
T305	Z 1706 1707	4
#305	Norm T305	4 Z
T306	NC 1707 1709	mg
#306	Norm T306	mg NC00000
T307	Fh 1709 1710	/
#307	Norm T307	/ Fh
T308	NC 1710 1712	kg
#308	Norm T308	kg NC00000
T309	AQ 1713 1723	subcutáneo
#309	Norm T309	subcutáneo AQ0FP0
T310	DI 1724 1728	cada
#310	Norm T310	cada DI0CS0
T311	Z 1729 1730	4
#311	Norm T311	4 Z
T312	NC 1731 1738	semanas
#312	Norm T312	semana NCFP000
T313	Fp 1738 1739	.
#313	Norm T313	. Fp
T314	DA 1740 1742	La
#314	Norm T314	el DA0FS0
T315	NC 1743 1746	CFT
#315	Norm T315	CFT NC00000
T316	VM 1747 1754	acuerda
#316	Norm T316	acordar VMIP3S0
T317	VM 1755 1764	aprobarlo
#317	Norm T317	aprobar+lo VMN0000+PP3CNA00
T318	CC 1765 1766	y
#318	Norm T318	y CC
T319	P0 1767 1769	se
#319	Norm T319	se P00CN000
T320	VM 1770 1776	inicia
#320	Norm T320	iniciar VMIP3S0
T321	NC 1777 1788	tratamiento
#321	Norm T321	tratamiento NCMS000
T322	SP 1789 1790	a
#322	Norm T322	a SPS00
T323	Z 1791 1792	2
#323	Norm T323	2 Z
T324	NC 1793 1795	mg
#324	Norm T324	mg NC00000
T325	Fh 1795 1796	/
#325	Norm T325	/ Fh
T326	NC 1796 1798	kg
#326	Norm T326	kg NC00000
T327	DI 1799 1803	cada
#327	Norm T327	cada DI0CS0
T328	Z 1804 1805	4
#328	Norm T328	4 Z
T329	NC 1806 1813	semanas
#329	Norm T329	semana NCFP000
T330	SP 1814 1818	para
#330	Norm T330	para SPS00
T331	VM 1819 1828	comprobar
#331	Norm T331	comprobar VMN0000
T332	NC 1829 1839	tolerancia
#332	Norm T332	tolerancia NCFS000
T333	Fp 1839 1840	.
#333	Norm T333	. Fp
T334	VM 1841 1845	Dado
#334	Norm T334	dar VMP00SM
T335	DA 1846 1848	el
#335	Norm T335	el DA0MS0
T336	NC 1849 1853	peso
#336	Norm T336	peso NCMS000
T337	SP 1854 1856	de
#337	Norm T337	de SPS00
T338	DA 1857 1859	la
#338	Norm T338	el DA0FS0
T339	NC 1860 1868	paciente
#339	Norm T339	paciente NCCS000
T340	Fc 1868 1869	,
#340	Norm T340	, Fc
T341	DA 1870 1872	el
#341	Norm T341	el DA0MS0
T342	NP 1873 1893	Servicio de Farmacia
#342	Norm T342	servicio_de_farmacia NP00000
T343	VM 1894 1903	reformula
#343	Norm T343	reformular VMIP3S0
T344	DA 1904 1906	el
#344	Norm T344	el DA0MS0
T345	NC 1907 1911	vial
#345	Norm T345	vial NCMS000
T346	SP 1912 1916	para
#346	Norm T346	para SPS00
T347	VM 1917 1922	poder
#347	Norm T347	poder VMN0000
T348	VM 1923 1933	utilizarlo
#348	Norm T348	utilizar+lo VMN0000+PP3CNA00
T349	SP 1934 1936	en
#349	Norm T349	en SPS00
T350	DI 1937 1943	varias
#350	Norm T350	varios DI0FP0
T351	NC 1944 1949	dosis
#351	Norm T351	dosis NCFN000
T352	CC 1950 1951	y
#352	Norm T352	y CC
T353	VS 1952 1955	ser
#353	Norm T353	ser VSN0000
T354	RG 1956 1959	más
#354	Norm T354	más RG
T355	AQ 1960 1969	eficiente
#355	Norm T355	eficiente AQ0CS0
T356	Fp 1969 1970	.
#356	Norm T356	. Fp
T357	P0 1971 1973	Se
#357	Norm T357	se P00CN000
T358	VM 1974 1981	observa
#358	Norm T358	observar VMIP3S0
T359	DI 1982 1985	una
#359	Norm T359	uno DI0FS0
T360	VM 1986 1994	adecuada
#360	Norm T360	adecuar VMP00SF
T361	NC 1995 2005	tolerancia
#361	Norm T361	tolerancia NCFS000
T362	CC 2006 2007	y
#362	Norm T362	y CC
T363	AQ 2008 2013	buena
#363	Norm T363	bueno AQ0FS0
T364	NC 2014 2023	respuesta
#364	Norm T364	respuesta NCFS000
T365	SP 2024 2026	al
#365	Norm T365	a+el SPS00+DA0MS0
T366	AQ 2027 2036	biológico
#366	Norm T366	biológico AQ0MS0
T367	SP 2037 2038	a
#367	Norm T367	a SPS00
T368	NC 2039 2044	dosis
#368	Norm T368	dosis NCFN000
T369	SP 2045 2047	de
#369	Norm T369	de SPS00
T370	Z 2048 2049	2
#370	Norm T370	2 Z
T371	NC 2050 2052	mg
#371	Norm T371	mg NC00000
T372	Fh 2052 2053	/
#372	Norm T372	/ Fh
T373	NC 2053 2055	kg
#373	Norm T373	kg NC00000
T374	Fh 2055 2056	/
#374	Norm T374	/ Fh
T375	Z 2056 2057	4
#375	Norm T375	4 Z
T376	NC 2058 2065	semanas
#376	Norm T376	semana NCFP000
T377	Fc 2065 2066	,
#377	Norm T377	, Fc
T378	VM 2067 2081	desapareciendo
#378	Norm T378	desaparecer VMG0000
T379	DA 2082 2085	los
#379	Norm T379	el DA0MP0
T380	NC 2086 2094	síntomas
#380	Norm T380	síntoma NCMP000
T381	Fc 2094 2095	,
#381	Norm T381	, Fc
T382	PR 2096 2099	que
#382	Norm T382	que PR0CN000
T383	VM 2100 2107	permite
#383	Norm T383	permitir VMIP3S0
T384	VM 2108 2115	reducir
#384	Norm T384	reducir VMN0000
T385	DA 2116 2118	la
#385	Norm T385	el DA0FS0
T386	NC 2119 2124	dosis
#386	Norm T386	dosis NCFN000
T387	SP 2125 2127	de
#387	Norm T387	de SPS00
T388	NC 2128 2138	corticoide
#388	Norm T388	corticoide NCMS000
T389	SP 2139 2140	a
#389	Norm T389	a SPS00
T390	Z 2141 2142	8
#390	Norm T390	8 Z
T391	NC 2143 2145	mg
#391	Norm T391	mg NC00000
T392	Fh 2145 2146	/
#392	Norm T392	/ Fh
T393	NC 2146 2149	día
#393	Norm T393	día NCMS000
T394	Fc 2149 2150	,
#394	Norm T394	, Fc
T395	VM 2151 2162	continuando
#395	Norm T395	continuar VMG0000
T396	DA 2163 2165	la
#396	Norm T396	el DA0FS0
T397	AQ 2166 2171	buena
#397	Norm T397	bueno AQ0FS0
T398	NC 2172 2181	evolución
#398	Norm T398	evolución NCFS000
T399	Fp 2181 2182	.
#399	Norm T399	. Fp
T400	P0 2183 2185	Se
#400	Norm T400	se P00CN000
T401	VM 2186 2193	aumenta
#401	Norm T401	aumentar VMIP3S0
T402	DA 2194 2196	la
#402	Norm T402	el DA0FS0
T403	NC 2197 2202	dosis
#403	Norm T403	dosis NCFN000
T404	SP 2203 2205	de
#404	Norm T404	de SPS00
T405	NC 2206 2217	canakinumab
#405	Norm T405	canakinumab NC00000
T406	SP 2218 2219	a
#406	Norm T406	a SPS00
T407	Z 2220 2221	3
#407	Norm T407	3 Z
T408	NC 2222 2224	mg
#408	Norm T408	mg NC00000
T409	Fh 2224 2225	/
#409	Norm T409	/ Fh
T410	NC 2225 2227	kg
#410	Norm T410	kg NC00000
T411	Fh 2227 2228	/
#411	Norm T411	/ Fh
T412	Z 2228 2229	4
#412	Norm T412	4 Z
T413	NC 2230 2237	semanas
#413	Norm T413	semana NCFP000
T414	CC 2238 2239	y
#414	Norm T414	y CC
T415	P0 2240 2242	se
#415	Norm T415	se P00CN000
T416	VM 2243 2251	desecala
#416	Norm T416	desescalar VMIP3S0
T417	DA 2252 2254	el
#417	Norm T417	el DA0MS0
T418	NC 2255 2265	corticoide
#418	Norm T418	corticoide NCMS000
T419	SP 2266 2271	hasta
#419	Norm T419	hasta SPS00
T420	VM 2272 2281	suspender
#420	Norm T420	suspender VMN0000
T421	Fp 2281 2282	.
#421	Norm T421	. Fp
T422	SP 2283 2287	Tras
#422	Norm T422	tras SPS00
T423	Z 2288 2289	6
#423	Norm T423	6 Z
T424	NC 2290 2295	meses
#424	Norm T424	mes NCMP000
T425	SP 2296 2298	de
#425	Norm T425	de SPS00
T426	NC 2299 2310	tratamiento
#426	Norm T426	tratamiento NCMS000
T427	VM 2311 2316	sufre
#427	Norm T427	sufrir VMIP3S0
T428	DI 2317 2320	una
#428	Norm T428	uno DI0FS0
T429	AQ 2321 2326	nueva
#429	Norm T429	nuevo AQ0FS0
T430	NC 2327 2334	recaída
#430	Norm T430	recaída NCFS000
T431	SP 2335 2338	con
#431	Norm T431	con SPS00
T432	NC 2339 2348	febrícula
#432	Norm T432	febrícula NCFS000
T433	VM 2349 2358	mantenida
#433	Norm T433	mantener VMP00SF
T434	Fc 2358 2359	,
#434	Norm T434	, Fc
T435	NC 2360 2373	irritabilidad
#435	Norm T435	irritabilidad NCFS000
T436	CC 2374 2375	y
#436	Norm T436	y CC
T437	DI 2376 2383	algunas
#437	Norm T437	alguno DI0FP0
T438	NC 2384 2392	lesiones
#438	Norm T438	lesión NCFP000
T439	AQ 2393 2401	cutáneas
#439	Norm T439	cutáneo AQ0FP0
T440	SP 2402 2405	por
#440	Norm T440	por SPS00
T441	DA 2406 2408	lo
#441	Norm T441	el DA0NS0
T442	PR 2409 2412	que
#442	Norm T442	que PR0CN000
T443	P0 2413 2415	se
#443	Norm T443	se P00CN000
T444	VM 2416 2422	aument
#444	Norm T444	aumentar VMIP3S0
T445	DA 2423 2425	la
#445	Norm T445	el DA0FS0
T446	NC 2426 2431	dosis
#446	Norm T446	dosis NCFN000
T447	SP 2432 2434	de
#447	Norm T447	de SPS00
T448	NC 2435 2446	canakinumab
#448	Norm T448	canakinumab NC00000
T449	SP 2447 2448	a
#449	Norm T449	a SPS00
T450	DA 2449 2451	la
#450	Norm T450	el DA0FS0
T451	AQ 2452 2458	óptima
#451	Norm T451	bueno AQSFS0
T452	VM 2459 2467	prevista
#452	Norm T452	prever VMP00SF
T453	SP 2468 2470	de
#453	Norm T453	de SPS00
T454	Z 2471 2472	4
#454	Norm T454	4 Z
T455	NC 2473 2475	mg
#455	Norm T455	mg NC00000
T456	Fh 2475 2476	/
#456	Norm T456	/ Fh
T457	NC 2476 2478	kg
#457	Norm T457	kg NC00000
T458	Fh 2478 2479	/
#458	Norm T458	/ Fh
T459	Z 2479 2480	4
#459	Norm T459	4 Z
T460	NC 2481 2488	semanas
#460	Norm T460	semana NCFP000
T461	Fc 2488 2489	,
#461	Norm T461	, Fc
T462	VM 2490 2505	reintroduciendo
#462	Norm T462	reintroducir VMG0000
T463	NC 2506 2517	corticoides
#463	Norm T463	corticoide NCMP000
T464	Fp 2517 2518	.
#464	Norm T464	. Fp
T465	DA 2519 2521	La
#465	Norm T465	el DA0FS0
T466	NC 2522 2532	enfermedad
#466	Norm T466	enfermedad NCFS000
T467	P0 2533 2535	se
#467	Norm T467	se P00CN000
T468	VM 2536 2543	mantuvo
#468	Norm T468	mantener VMIS3S0
T469	AQ 2544 2551	estable
#469	Norm T469	estable AQ0CS0
T470	SP 2552 2553	a
#470	Norm T470	a SPS00
T471	VM 2554 2559	pesar
#471	Norm T471	pesar VMN0000
T472	SP 2560 2562	de
#472	Norm T472	de SPS00
T473	DI 2563 2565	un
#473	Norm T473	uno DI0MS0
T474	NC 2566 2573	proceso
#474	Norm T474	proceso NCMS000
T475	AQ 2574 2584	infeccioso
#475	Norm T475	infeccioso AQ0MS0
T476	PR 2585 2588	que
#476	Norm T476	que PR0CN000
T477	VM 2589 2595	remite
#477	Norm T477	remitir VMIP3S0
T478	SP 2596 2599	sin
#478	Norm T478	sin SPS00
T479	NC 2600 2614	complicaciones
#479	Norm T479	complicación NCFP000
T480	AQ 2615 2626	secundarias
#480	Norm T480	secundario AQ0FP0
T481	Fc 2626 2627	,
#481	Norm T481	, Fc
T482	SP 2628 2635	durante
#482	Norm T482	durante SPS00
T483	DA 2636 2638	el
#483	Norm T483	el DA0MS0
T484	PR 2639 2643	cual
#484	Norm T484	cual PR0CS000
T485	P0 2644 2646	se
#485	Norm T485	se P00CN000
T486	VM 2647 2655	suspende
#486	Norm T486	suspender VMIP3S0
T487	DA 2656 2658	la
#487	Norm T487	el DA0FS0
T488	NC 2659 2673	administración
#488	Norm T488	administración NCFS000
T489	SP 2674 2677	del
#489	Norm T489	de+el SPS00+DA0MS0
T490	AQ 2678 2687	biológico
#490	Norm T490	biológico AQ0MS0
T491	Fp 2687 2688	.
#491	Norm T491	. Fp
T492	SP 2689 2690	A
#492	Norm T492	A SPS00
T493	DA 2691 2694	los
#493	Norm T493	el DA0MP0
T494	Z 2695 2696	7
#494	Norm T494	7 Z
T495	NC 2697 2702	meses
#495	Norm T495	mes NCMP000
T496	SP 2703 2705	de
#496	Norm T496	de SPS00
T497	NC 2706 2717	tratamiento
#497	Norm T497	tratamiento NCMS000
T498	P0 2718 2720	se
#498	Norm T498	se P00CN000
T499	VM 2721 2726	añade
#499	Norm T499	añadir VMIP3S0
T500	NC 2727 2738	metotrexate
#500	Norm T500	metotrexato NCMS000
T501	Z 2739 2742	7,5
#501	Norm T501	7.5 Z
T502	NC 2743 2745	mg
#502	Norm T502	mg NC00000
T503	Fh 2745 2746	/
#503	Norm T503	/ Fh
T504	AQ 2746 2753	semanal
#504	Norm T504	semanal AQ0CS0
T505	AQ 2754 2764	subcutáneo
#505	Norm T505	subcutáneo AQ0FP0
T506	VM 2765 2770	junto
#506	Norm T506	juntar VMIP1S0
T507	SP 2771 2774	con
#507	Norm T507	con SPS00
T508	NC 2775 2783	folinato
#508	Norm T508	folinato NCMS000
T509	AQ 2784 2791	cálcico
#509	Norm T509	cálcico AQ0MS0
T510	Fc 2791 2792	,
#510	Norm T510	, Fc
T511	Z 2793 2794	7
#511	Norm T511	7 Z
T512	NC 2795 2797	mg
#512	Norm T512	mg NC00000
T513	Fh 2797 2798	/
#513	Norm T513	/ Fh
T514	NC 2798 2804	semana
#514	Norm T514	semana NCFS000
T515	Fc 2804 2805	,
#515	Norm T515	, Fc
T516	VM 2806 2812	debido
#516	Norm T516	deber VMP00SM
T517	SP 2813 2815	al
#517	Norm T517	a+el SPS00+DA0MS0
T518	NC 2816 2826	desarrollo
#518	Norm T518	desarrollo NCMS000
T519	SP 2827 2829	de
#519	Norm T519	de SPS00
T520	NC 2830 2845	manifestaciones
#520	Norm T520	manifestación NCFP000
T521	AQ 2846 2857	articulares
#521	Norm T521	articular AQ0CP0
T522	SP 2858 2860	en
#522	Norm T522	en SPS00
T523	NC 2861 2866	codos
#523	Norm T523	codo NCMP000
T524	CC 2867 2868	y
#524	Norm T524	y CC
T525	NC 2869 2875	carpos
#525	Norm T525	carpo NCMP000
T526	PR 2876 2879	que
#526	Norm T526	que PR0CN000
T527	VM 2880 2888	aparecen
#527	Norm T527	aparecer VMIP3P0
T528	AQ 2889 2898	dolorosos
#528	Norm T528	doloroso AQ0MP0
T529	CC 2899 2900	e
#529	Norm T529	y CC
T530	VM 2901 2911	inflamados
#530	Norm T530	inflamar VMP00PM
T531	Fp 2911 2912	.
#531	Norm T531	. Fp
T532	Z 2913 2917	Ocho
#532	Norm T532	8 Z
T533	NC 2918 2925	semanas
#533	Norm T533	semana NCFP000
T534	RG 2926 2933	después
#534	Norm T534	después RG
T535	P0 2934 2936	se
#535	Norm T535	se P00CN000
T536	VM 2937 2944	produce
#536	Norm T536	producir VMIP3S0
T537	DI 2945 2947	un
#537	Norm T537	uno DI0MS0
T538	NC 2948 2954	cuadro
#538	Norm T538	cuadro NCMS000
T539	SP 2955 2958	con
#539	Norm T539	con SPS00
T540	NC 2959 2969	alteración
#540	Norm T540	alteración NCFS000
T541	SP 2970 2972	de
#541	Norm T541	de SPS00
T542	DA 2973 2975	la
#542	Norm T542	el DA0FS0
T543	NC 2976 2987	coagulación
#543	Norm T543	coagulación NCFS000
T544	CC 2988 2989	e
#544	Norm T544	y CC
T545	NC 2990 3007	hipertrasaminemia
#545	Norm T545	hipertrasaminasemia NCFS000
T546	Fc 3007 3008	,
#546	Norm T546	, Fc
T547	RG 3009 3022	probablemente
#547	Norm T547	probablemente RG
T548	AQ 3023 3033	secundario
#548	Norm T548	secundario AQ0MS0
T549	SP 3034 3036	al
#549	Norm T549	a+el SPS00+DA0MS0
T550	NC 3037 3048	tratamiento
#550	Norm T550	tratamiento NCMS000
T551	SP 3049 3052	con
#551	Norm T551	con SPS00
T552	NC 3053 3064	metotrexate
#552	Norm T552	metotrexato NCMS000
T553	Fc 3064 3065	,
#553	Norm T553	, Fc
T554	CC 3066 3067	y
#554	Norm T554	y CC
T555	NC 3068 3079	monocitosis
#555	Norm T555	monocitosis NCFN000
T556	PR 3080 3083	que
#556	Norm T556	que PR0CN000
T557	VM 3084 3090	obliga
#557	Norm T557	obligar VMIP3S0
T558	SP 3091 3092	a
#558	Norm T558	a SPS00
T559	DP 3093 3095	su
#559	Norm T559	su DP3CS0
T560	NC 3096 3103	ingreso
#560	Norm T560	ingreso NCMS000
T561	CC 3104 3105	y
#561	Norm T561	y CC
T562	DA 3106 3108	la
#562	Norm T562	el DA0FS0
T563	NC 3109 3119	suspensión
#563	Norm T563	suspensión NCFS000
T564	SP 3120 3122	de
#564	Norm T564	de SPS00
T565	NC 3123 3134	metotrexate
#565	Norm T565	metotrexato NCMS000
T566	CC 3135 3136	y
#566	Norm T566	y CC
T567	NC 3137 3148	canakinumab
#567	Norm T567	canakinumab NC00000
T568	Fp 3148 3149	.
#568	Norm T568	. Fp
T569	SP 3150 3157	Durante
#569	Norm T569	durante SPS00
T570	DA 3158 3160	el
#570	Norm T570	el DA0MS0
T571	NC 3161 3168	ingreso
#571	Norm T571	ingreso NCMS000
T572	DA 3169 3171	la
#572	Norm T572	el DA0FS0
T573	NC 3172 3180	paciente
#573	Norm T573	paciente NCCS000
T574	VM 3181 3191	evoluciona
#574	Norm T574	evolucionar VMIP3S0
T575	RG 3192 3206	favorablemente
#575	Norm T575	favorablemente RG
T576	CC 3207 3208	y
#576	Norm T576	y CC
T577	P0 3209 3211	se
#577	Norm T577	se P00CN000
T578	VM 3212 3223	diagnostica
#578	Norm T578	diagnosticar VMIP3S0
T579	SP 3224 3226	de
#579	Norm T579	de SPS00
T580	NP 3227 3231	AlJs
#580	Norm T580	aljs NP00000
T581	SP 3232 3234	de
#581	Norm T581	de SPS00
T582	NC 3235 3240	curso
#582	Norm T582	curso NCMS000
T583	AQ 3241 3254	poliarticular
#583	Norm T583	poliarticular AQ0CS0
T584	AQ 3255 3261	activa
#584	Norm T584	activo AQ0FS0
T585	Fc 3261 3262	,
#585	Norm T585	, Fc
T586	SP 3263 3266	por
#586	Norm T586	por SPS00
T587	DA 3267 3269	lo
#587	Norm T587	el DA0NS0
T588	PR 3270 3273	que
#588	Norm T588	que PR0CN000
T589	P0 3274 3276	se
#589	Norm T589	se P00CN000
T590	VM 3277 3283	decide
#590	Norm T590	decidir VMIP3S0
T591	VM 3284 3291	iniciar
#591	Norm T591	iniciar VMN0000
T592	NC 3292 3302	etanercept
#592	Norm T592	etanercept NC00000
T593	Z 3303 3306	0,4
#593	Norm T593	0.4 Z
T594	NC 3307 3309	mg
#594	Norm T594	mg NC00000
T595	Fh 3309 3310	/
#595	Norm T595	/ Fh
T596	NC 3310 3312	kg
#596	Norm T596	kg NC00000
T597	Fh 3312 3313	/
#597	Norm T597	/ Fh
T598	NC 3313 3319	semana
#598	Norm T598	semana NCFS000
T599	NC 3320 3323	vía
#599	Norm T599	vía NCFS000
T600	AQ 3324 3334	subcutánea
#600	Norm T600	subcutáneo AQ0FP0
T601	SP 3335 3339	para
#601	Norm T601	para SPS00
T602	DA 3340 3342	el
#602	Norm T602	el DA0MS0
T603	NC 3343 3354	tratamiento
#603	Norm T603	tratamiento NCMS000
T604	SP 3355 3357	de
#604	Norm T604	de SPS00
T605	DA 3358 3361	las
#605	Norm T605	el DA0FP0
T606	NC 3362 3377	manifestaciones
#606	Norm T606	manifestación NCFP000
T607	AQ 3378 3389	articulares
#607	Norm T607	articular AQ0CP0
T608	Fp 3389 3390	.
#608	Norm T608	. Fp
T609	CC 3391 3397	Aunque
#609	Norm T609	aunque CC
T610	DA 3398 3400	la
#610	Norm T610	el DA0FS0
T611	NC 3401 3410	respuesta
#611	Norm T611	respuesta NCFS000
T612	AQ 3411 3418	clínica
#612	Norm T612	clínico AQ0FS0
T613	SP 3419 3421	al
#613	Norm T613	a+el SPS00+DA0MS0
T614	AQ 3422 3427	nuevo
#614	Norm T614	nuevo AQ0MS0
T615	AQ 3428 3437	biológico
#615	Norm T615	biológico AQ0MS0
T616	VS 3438 3440	es
#616	Norm T616	ser VSIP3S0
T617	AQ 3441 3454	satisfactoria
#617	Norm T617	satisfactorio AQ0FS0
T618	Fc 3454 3455	,
#618	Norm T618	, Fc
T619	P0 3456 3458	se
#619	Norm T619	se P00CN000
T620	VM 3459 3467	suspende
#620	Norm T620	suspender VMIP3S0
T621	DP 3468 3470	su
#621	Norm T621	su DP3CS0
T622	NC 3471 3485	administración
#622	Norm T622	administración NCFS000
T623	SP 3486 3493	durante
#623	Norm T623	durante SPS00
T624	Z 3494 3496	15
#624	Norm T624	15 Z
T625	NC 3497 3501	días
#625	Norm T625	día NCMP000
T626	VM 3502 3508	debido
#626	Norm T626	deber VMP00SM
T627	SP 3509 3510	a
#627	Norm T627	a SPS00
T628	DI 3511 3514	una
#628	Norm T628	uno DI0FS0
T629	AQ 3515 3520	nueva
#629	Norm T629	nuevo AQ0FS0
T630	NC 3521 3530	elevación
#630	Norm T630	elevación NCFS000
T631	SP 3531 3533	de
#631	Norm T631	de SPS00
T632	DA 3534 3537	las
#632	Norm T632	el DA0FP0
T633	NC 3538 3551	transaminasas
#633	Norm T633	transaminasa NCFP000
T634	SP 3552 3557	hasta
#634	Norm T634	hasta SPS00
T635	DP 3558 3560	su
#635	Norm T635	su DP3CS0
T636	NC 3561 3571	resolución
#636	Norm T636	resolución NCFS000
T637	Fp 3571 3572	.
#637	Norm T637	. Fp
T638	Z 3573 3574	2
#638	Norm T638	2 Z
T639	NC 3575 3580	meses
#639	Norm T639	mes NCMP000
T640	RG 3581 3588	después
#640	Norm T640	después RG
T641	DA 3589 3591	la
#641	Norm T641	el DA0FS0
T642	NC 3592 3600	paciente
#642	Norm T642	paciente NCCS000
T643	VM 3601 3608	ingresa
#643	Norm T643	ingresar VMIP3S0
T644	SP 3609 3613	para
#644	Norm T644	para SPS00
T645	NC 3614 3627	artrocentesis
#645	Norm T645	artrocentesis NCCN000
T646	SP 3628 3630	en
#646	Norm T646	en SPS00
T647	DI 3631 3636	ambas
#647	Norm T647	ambos DI0FP0
T648	NC 3637 3645	rodillas
#648	Norm T648	rodilla NCFP000
T649	Fp 3645 3646	.
#649	Norm T649	. Fp
T650	SP 3647 3648	A
#650	Norm T650	A SPS00
T651	VM 3649 3655	partir
#651	Norm T651	partir VMN0000
T652	SP 3656 3658	de
#652	Norm T652	de SPS00
T653	RG 3659 3667	entonces
#653	Norm T653	entonces RG
T654	DA 3668 3670	la
#654	Norm T654	el DA0FS0
T655	NC 3671 3679	paciente
#655	Norm T655	paciente NCCS000
T656	VM 3680 3688	mantiene
#656	Norm T656	mantener VMIP3S0
T657	DA 3689 3691	el
#657	Norm T657	el DA0MS0
T658	NC 3692 3703	tratamiento
#658	Norm T658	tratamiento NCMS000
T659	SP 3704 3707	con
#659	Norm T659	con SPS00
T660	NC 3708 3718	etanercept
#660	Norm T660	etanercept NC00000
T661	Z 3719 3722	0,4
#661	Norm T661	0.4 Z
T662	NC 3722 3724	mg
#662	Norm T662	mg NC00000
T663	Fh 3724 3725	/
#663	Norm T663	/ Fh
T664	NC 3725 3731	semana
#664	Norm T664	semana NCFS000
T665	VM 3732 3743	continuando
#665	Norm T665	continuar VMG0000
T666	DA 3744 3746	la
#666	Norm T666	el DA0FS0
T667	NC 3747 3754	mejoría
#667	Norm T667	mejoría NCFS000
T668	SP 3755 3758	sin
#668	Norm T668	sin SPS00
T669	NC 3759 3767	lesiones
#669	Norm T669	lesión NCFP000
T670	AQ 3768 3776	cutáneas
#670	Norm T670	cutáneo AQ0FP0
T671	CC 3777 3779	ni
#671	Norm T671	ni CC
T672	NC 3780 3786	fiebre
#672	Norm T672	fiebre NCFS000
T673	CC 3787 3788	y
#673	Norm T673	y CC
T674	VM 3789 3800	permitiendo
#674	Norm T674	permitir VMG0000
T675	DA 3801 3803	el
#675	Norm T675	el DA0MS0
T676	NC 3804 3812	descenso
#676	Norm T676	descenso NCMS000
T677	SP 3813 3815	de
#677	Norm T677	de SPS00
T678	NC 3816 3827	corticoides
#678	Norm T678	corticoide NCMP000
T679	SP 3828 3833	hasta
#679	Norm T679	hasta SPS00
T680	Z 3834 3835	4
#680	Norm T680	4 Z
T681	NC 3836 3838	mg
#681	Norm T681	mg NC00000
T682	Fh 3838 3839	/
#682	Norm T682	/ Fh
T683	NC 3839 3842	día
#683	Norm T683	día NCMS000
T684	Fp 3842 3843	.
#684	Norm T684	. Fp
